Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Seto

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Imaging|November 11, 2011
Angiomyolipomas of the mediastinum and the lungKoichiro Morita, Yoshitaka Shida, Kenji Shinozaki, et al.
Anticancer Research|January 30, 2008
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growthKazutsugu Uematsu, Nobuhiko Seki, Takashi Seto, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2013
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumoursTakashi Seto, Taito Esaki, Fumihiko Hirai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2015
Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer or Other TumorsMakoto Nishio, Haruyasu Murakami, Atsushi Horiike, et al.
Journal of Thoracic Disease|October 29, 2019
Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumabTaro Ohba, Shinkichi Takamori, Ryo Toyozawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II studyYuichi Takiguchi, Takashi Seto, Yukito Ichinose, et al.
Journal of Thoracic Disease|September 22, 2017
Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case reportMakoto Edagawa, Naoki Haratake, Shinichiro Shimamatsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinumTakashi Seto, Takeharu Yamanaka, Makiko Nakano, et al.
Journal of Cardiology Cases|December 15, 2018
A case of anticoagulant treatment-resistant Trousseau syndrome controlled by treatment of the underlying lung adenocarcinoma: Utility of monitoring D-dimer levelsSo Kuwahata, Toshihiro Takenaka, Shunsuke Yasuda, et al.
The Annals of Thoracic Surgery|May 20, 2019
The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung CancerShinichiro Shimamatsu, Mitsuhiro Takenoyama, Mototsugu Shimokawa, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Imaging|November 11, 2011
Angiomyolipomas of the mediastinum and the lungKoichiro Morita, Yoshitaka Shida, Kenji Shinozaki, et al.
Anticancer Research|January 30, 2008
Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growthKazutsugu Uematsu, Nobuhiko Seki, Takashi Seto, et al.
Cancer Chemotherapy and Pharmacology|July 30, 2013
Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumoursTakashi Seto, Taito Esaki, Fumihiko Hirai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 29, 2015
Phase I Study of Ceritinib (LDK378) in Japanese Patients with Advanced, Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer or Other TumorsMakoto Nishio, Haruyasu Murakami, Atsushi Horiike, et al.
Journal of Thoracic Disease|October 29, 2019
Prognostic impact of the Controlling Nutritional Status score in patients with non-small cell lung cancer treated with pembrolizumabTaro Ohba, Shinkichi Takamori, Ryo Toyozawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 26, 2010
Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II studyYuichi Takiguchi, Takashi Seto, Yukito Ichinose, et al.
Journal of Thoracic Disease|September 22, 2017
Surgical resection of a well-differentiated inflammatory liposarcoma of the middle mediastinum: a case reportMakoto Edagawa, Naoki Haratake, Shinichiro Shimamatsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2008
Tegafur-uracil plus gemcitabine combination chemotherapy in patients with advanced non-small cell lung cancer previously treated with platinumTakashi Seto, Takeharu Yamanaka, Makiko Nakano, et al.
Journal of Cardiology Cases|December 15, 2018
A case of anticoagulant treatment-resistant Trousseau syndrome controlled by treatment of the underlying lung adenocarcinoma: Utility of monitoring D-dimer levelsSo Kuwahata, Toshihiro Takenaka, Shunsuke Yasuda, et al.
The Annals of Thoracic Surgery|May 20, 2019
The Influence of Clinical T Factor on Predicting Pathologic N Factor in Resected Lung CancerShinichiro Shimamatsu, Mitsuhiro Takenoyama, Mototsugu Shimokawa, et al.
Pageof 25